Nerve Excitability and Structural Changes in Myelinated Axons from Diabetic Mice

Abstract

Objective: The mechanisms associated with nerve dysfunction and axonal loss in diabetes has not been fully clarified. Excitability and pathological aspects in nerves from diabetic mice were studied in order to explore the pathophysiology of diabetic neuropathy.

Methods: Myelinated nerve fibres from the sciatic nerve of BKS.Cg-m ^+/+ Lepr ^db /J mice were studied by registering the CMAP controlled by an automated threshold tracking method. The sciatic nerve was also studied pathologically.

Results: Diabetic mice displayed longer latencies, higher thresholds and lower amplitudes compared to controls and had a rightward shift in the stimulus response curves. Strength-duration time constant was lower in diabetic mice but not reaching statistical significance (p=0.09). Diabetics displayed an increase in accommodation, with a smaller change in excitability in threshold electrotonus. Refractoriness, mean superexcitability and late subexcitability were reduced in diabetic mice. Diabetic mice had a larger number of myelinated fibres compared to controls (p<0.05), but larger than 9 μm were virtually absent, accounting for near 7% in control animals.

Conclusions: Db/db mice develop electrophysiological changes suggestive of membrane depolarization as the result of Na⁺/K⁺ pump impairment. Loss of large myelinated fibres might also contribute to the nerve excitability profiles in this model.

Key words

db/db diabetic mice - nerve excitability - Na/K pump - myelinated fibers

• References

• 1 Arnold R, Kwai N et al. Axonal dysfunction prior to neuropathy onset in type 1 diabetes. Diabetes Metab Res Rev 2013; 29: 53-59
• 3 Baker M, Bostock H. Depolarization changes the mechanism of accommodation in rat and human motor axons. J Physiol 1989; 411: 545-561
• 5 Behse F, Buchthal F et al. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977; 40: 1072-1082
• 7 Bradley JL, Thomas PK et al. Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: correlation with type of diabetes. Acta Neuropathol 1995; 90: 403-410
• 9 Brismar T, Sima AA et al. Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol 1987; 21: 504-507
• 11 Burke D, Kiernan MC et al. Excitability of human axons. Clin Neurophysiol 2001; 112: 1575-1585
• 13 Greene D. The pathogenesis and prevention of diabetic neuropathy and nephropathy. Metabolism 1988; 37 (Suppl. 01) 25-29
• 15 Islam MS. Animal models of diabetic neuropathy: progress since 1960s. J Diabetes Res 2013; 2013: 149452
• 17 Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000; 123 (Pt 12) 2542-2551
• 19 Kitano Y, Kuwabara S et al. The acute effects of glycemic control on axonal excitability in human diabetics. Ann Neurol 2004; 56: 462-467
• 21 Krishnan AV, Kiernan MC. Altered nerve excitability properties in established diabetic neuropathy. Brain 2005; 128 (Pt 5) 1178-1187
• 23 Krishnan AV, Lin CS et al. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy. Brain 2008; 131 (Pt 5) 1209-1216
• 25 Malik RA, Tesfaye S et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005; 48: 578-585
• 27 McCallum KN, Sharma AK et al. The effect of continuous subcutaneous insulin infusion therapy on morphological and biochemical abnormalities of peripheral nerves in experimental diabetes. J Neurol Sci 1986; 74: 55-67
• 29 Sassoli V, Carvalho C et al. Diabetic Peripheral Neuropathies: A Morphometric Overview. Int J Morph 2010; 28: 51-64
• 31 Sharma AK, Thomas PK et al. Peripheral nerve abnormalities in the diabetic mutant mouse. Diabetes 1983; 32: 1152-1161
• 33 Sima AA. Structure-function interactions in the therapeutic response of diabetic neuropathy. J Diabetes Complications 1992; 6: 64-68
• 35 Sima AA, Brismar T. Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol 1985; 18: 21-29
• 37 Sung JY, Park SB et al. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. Diabetes 2012; 61: 1592-1598
• 39 Thomas PK. The morphological basis for alterations in nerve conduction in peripheral neuropathy. Proc R Soc Med 1971; 64: 295-298
• 41 Trevillion L, Howells J et al. Properties of low-threshold motor axons in the human median nerve. J Physiol 2010; 588 (Pt 13) 2503-2515
• 43 Yang Q, Kaji R et al. Abnormal axonal inward rectifier in streptozocin-induced experimental diabetic neuropathy. Brain 2001; 124 (Pt 6) 1149-1155
• 45 Yorek MA, Wiese TJ et al. Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation. Diabetes 1993; 42: 1401-1406